Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
17 January, 2019 00:04 IST
Camson Biotechnologies signs MoU with Coconut Development Board
Source: IRIS | 13 Mar, 2015, 04.23PM
Comments  |  Post Comment

Camson Bio Technologies, inked a Memorandum of Understanding (MoU) with Coconut Development Board (CDB), to develop non-chemical, zero-residue, secondary metabolite based biocides to control red palm weevil (Ryhnchophorus ferrugineus) infesting coconut plantations.

Secondary metabolite based solutions are the most advance technologies used to make farm inputs in the organic space and Camson is the only company in the country with the requisite research experience and execution skills. Camson has been partnered under the board's scheme ''Technology Mission of Coconut'' to conduct research over a period spanning to years.

Shares of the company gained Rs 1, or 1.02%, to settle at Rs 99. The total volume of shares traded was 162,334 at the BSE (Friday).



Camson Bio Technologies Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Suven Life Sciences secures 2 overseas product patents - 16-Jan-2019 13:45
Texmaco Rail & Engineering receives orders worth Rs 2.62 bn - 16-Jan-2019 12:59
Dr Reddy's announces completion of USFDA audit of formulation facility - 16-Jan-2019 10:15
HG Infra bags NHAI road project worth Rs 5.65 bn - 15-Jan-2019 10:29
L&T Hydrocarbon consortium wins EPCI order from Saudi Aramco - 15-Jan-2019 10:24
Zydus Cadila gets final approval from USFDA for 2 drugs - 15-Jan-2019 10:20
AGC Networks completes acquisition of Black Box Corporation - 10-Jan-2019 10:31
Glenmark Pharma enters into licensing agreement with Yuhan for commercializing Ryaltris in South Korea - 10-Jan-2019 10:28
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer